U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 10 of 11 results

Status:
US Approved Rx (2021)
First approved in 2000

Class (Stereo):
CHEMICAL (EPIMERIC)

Targets:


Argatroban is a synthetic direct thrombin inhibitor derived from L-arginine. Argatroban is a direct thrombin inhibitor that reversibly binds to the thrombin active site. Argatroban does not require the co-factor antithrombin III for antithrombotic ac...
Status:
US Approved Rx (2023)
First approved in 1953

Class (Stereo):
CHEMICAL (ACHIRAL)



Edetic acid (EDTA) is a chelating agent. The U.S. Food and Drug Administration (FDA) approved edetic acid chelation therapy as a treatment for lead and heavy metal poisoning. Edetic acid in form of disodium salt was withdrawn from the market due to d...
Status:
US Approved OTC
First marketed in 1921

Class (Stereo):
CHEMICAL (ACHIRAL)



Potassium citrate is indicated for the management of renal tubular acidosis with calcium stones, hypocitraturic calcium oxalate nephrolithiasis of any etiology, uric acid lithiasis with or without calcium stones. WhenPotassium citrate is given orally...
Status:
US Approved Rx (2019)
First approved in 2000

Class:
PROTEIN

Targets:

Conditions:

Bivalirudin is a synthetic 20 amino acid peptide rationally designed based on structural studies of hirudin, a naturally occurring anticoagulant. Bivalirudin is sold under the brand name Angiomax and is indicated for use as an anticoagulant in patien...
Status:
US Previously Marketed
First approved in 2003

Class:
PROTEIN


Desirudin (Iprivask), a recombinant hirudin, is a parenteral direct thrombin inhibitor approved to prevent venous thromboembolism in patients undergoing elective hip replacement surgery. Desirudin is a potent inhibitor of both clot-bound and freely c...
Status:
US Previously Marketed
First approved in 1998

Class:
PROTEIN


Lepirudin is a direct thrombin inhibitor obtained by recombinant technology from the medicinal leech and used for treatment of heparin-induced thrombocytopenia (HIT). Lepirudin was the first direct thrombin inhibitor approved and most frequently used...
Status:
Possibly Marketed Outside US
First approved in 2007

Class:
PROTEIN

Status:
US Approved Rx (1994)
First approved in 1994

Class:
POLYMER

Status:
US Approved Rx (2020)
First approved in 1939

Class:
POLYMER



Нeparin (or Unfractionated heparin ) is an anticoagulant indicated for both the prevention and treatment of thrombotic events such as deep vein thrombosis (DVT) and pulmonary embolism (PE) as well as atrial fibrillation (AF). Heparin can also be used...
Status:
US Approved Rx (2021)
First approved in 2000

Class (Stereo):
CHEMICAL (EPIMERIC)

Targets:


Argatroban is a synthetic direct thrombin inhibitor derived from L-arginine. Argatroban is a direct thrombin inhibitor that reversibly binds to the thrombin active site. Argatroban does not require the co-factor antithrombin III for antithrombotic ac...

Showing 1 - 10 of 11 results